A longitudinal study of 101 SLE patients over 15 years revealed that the risk of thrombosis gradually increased with the number of positive aPL, reaching a 30-fold higher risk when four antibody tests (anti-PT, aCL, aβ2GPI, and LA) were all positive [58]. The gene discussed is FASLG; the disease is systemic lupus erythematosus.